Unveiling the VEGFR2–TTI1–mTORC1 Axis: A Crucial Pathway in Hypoxia‐Induced Erythropoiesis
Authors:
- 18 May 2026
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 241 (5) , e70190
Abstract
Erythropoiesis is a meticulously regulated process influenced by a multitude of factors. Prior research has demonstrated that hypoxic conditions (5% O 2 ) facilitate erythroid differentiation. Nevertheless, although our preliminary data indicate the involvement of VEGF/VEGFR2 in this process, the precise regulatory mechanism in erythropoiesis under hypoxia remains inadequately understood. In this study, an in vitro model of inhibited erythroid differentiation was developed using CD34 + hematopoietic stem cells treated with a VEGFR2‐neutralizing antibody. Additionally, the signaling axis was modulated under hypoxia conditions employing the mTOR inhibitor rapamycin and TTI1 ‐siRNA. The findings revealed that hypoxia significantly upregulated VEGF/VEGFR2 expression and promoted erythroid differentiation. Conversely, VEGFR2 inhibition resulted in a substantial decrease in erythroid surface markers and hemoglobin synthesis. Proteomics analysis suggested that TTI1 and mTOR are pivotal components of this signaling axis, with their suppression effectively impeding erythropoiesis. Under hypoxic conditions, VEGFR2 may regulate erythroid differentiation of CD34 + cells through a mechanism involving the TTI1–mTORC1 signaling pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81971778)
This publication has 40 references indexed in Scilit:
- An erythroid-biased FOShi hematopoietic multipotent progenitor subpopulation contributes to adaptation to chronic hypoxiaCell Stem Cell, 2025
- mTORC2 orchestrates monocytic and granulocytic lineage commitment by an ATF5-mediated pathwayiScience, 2023
- Structure of the Human TELO2-TTI1-TTI2 ComplexJournal of Molecular Biology, 2022
- Hypoxia promotes erythroid differentiation through the development of progenitors and proerythroblastsExperimental Hematology, 2021
- mTOR Signaling as a Regulator of Hematopoietic Stem Cell FateStem Cell Reviews and Reports, 2021
- The opposing roles of the mTOR signaling pathway in different phases of human umbilical cord blood-derived CD34+ cell erythropoiesisStem Cells, 2020
- mTORC signaling in hematopoiesisInternational Journal of Hematology, 2016
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- Engraftment and Reconstitution of Hematopoiesis Is Dependent on VEGFR2-Mediated Regeneration of Sinusoidal Endothelial CellsCell Stem Cell, 2009
- Hematopoiesis: An Evolving Paradigm for Stem Cell BiologyCell, 2008